FOR EMPLOYERS
Improved Tolerability Stronger Outcomes
Our technologies support tolerability and adherence - without complicating delivery.
Fewer side-effect costs
Better treatment adherence
Less pressure on clinics
FOR EMPLOYERS
Improved Tolerability Stronger Outcomes
Our technologies support tolerability and adherence - without complicating delivery.
Fewer side-effect costs
Better treatment adherence
Less pressure on clinics
FOR EMPLOYERS
Improved Tolerability Stronger Outcomes
Our technologies support tolerability and adherence - without complicating delivery.
Fewer side-effect costs
Better treatment adherence
Less pressure on clinics
More continuity at work
Lotus helps shift eligible treatment into the home to reduce time away from work and ease the logistics of ongoing care.
32% of patients' days are spent in oncology clinics
More continuity at work
Lotus helps shift eligible treatment into the home to reduce time away from work and ease the logistics of ongoing care.
32% of patients' days are spent in oncology clinics
More continuity at work
Lotus helps shift eligible treatment into the home to reduce time away from work and ease the logistics of ongoing care.
32% of patients' days are spent in oncology clinics
Improved comfort and focus
Lilac helps manage nerve pain that interferes with daily tasks, typing, or mobility—so employees can focus on healing and working when they choose.
68% of cancer patients experience life-changing neuropathy
Improved comfort and focus
Lilac helps manage nerve pain that interferes with daily tasks, typing, or mobility—so employees can focus on healing and working when they choose.
68% of cancer patients experience life-changing neuropathy
Improved comfort and focus
Lilac helps manage nerve pain that interferes with daily tasks, typing, or mobility—so employees can focus on healing and working when they choose.
68% of patients get life-changing neuropathy due to treatment
Support for identity at work
Lily aims to reduce hair loss during treatment, supporting privacy, confidence, and normalcy during a difficult time.
47% of breast cancer patients find hair loss highly traumatic
Support for identity at work
Lily aims to reduce hair loss during treatment, supporting privacy, confidence, and normalcy during a difficult time.
47% of breast cancer patients find hair loss highly traumatic
Support for identity at work
Lily aims to reduce hair loss during treatment, supporting privacy, confidence, and normalcy during a difficult time.
47% of breast cancer patients find hair loss highly traumatic
Built for impact where it matters most.
More than half of employers view cancer care as the primary driver of their healthcare costs. We design our solutions to reduce workplace disruption, ease the strain of treatment, and improve how employees experience care. Because when people feel seen and supported, they’re more likely to stay engaged, with their health and their work.
Built for impact where it matters most.
More than half of employers view cancer care as the primary driver of their healthcare costs. We design our solutions to reduce workplace disruption, ease the strain of treatment, and improve how employees experience care. Because when people feel seen and supported, they’re more likely to stay engaged, with their health and their work.
Built for impact where it matters most.
More than half of employers view cancer care as the primary driver of their healthcare costs. We design our solutions to reduce workplace disruption, ease the strain of treatment, and improve how employees experience care. Because when people feel seen and supported, they’re more likely to stay engaged, with their health and their work.
“
No one can tell you've undergone chemotherapy.
”
Lily Clinical Trial Participant
“
No one can tell you've undergone chemotherapy.
”
Lily Clinical Trial Participant
“
No one can tell you've undergone chemotherapy.
”
Lily Clinical Trial Participant
Technologies that support your team
We’re building a growing set of solutions—each designed to solve a different barrier to delivering better cancer care at scale.
Scaling Home Infusion
The UPenn Cancer Care @ Home program scaled by more than 700% month-on-month during the COVID-19 pandemic.
Scaling Home Infusion
The UPenn Cancer Care @ Home program scaled by more than 700% month-on-month during the COVID-19 pandemic.
Scaling Home Infusion
The UPenn Cancer Care @ Home program scaled by more than 700% month-on-month during the COVID-19 pandemic.
Rural Home Infusion
The VA’s Close to Me program has trialled subcutaneous infusions in the home in rural settings to great success, enabling better access to care.
Rural Home Infusion
The VA’s Close to Me program has trialled subcutaneous infusions in the home in rural settings to great success, enabling better access to care.
Rural Home Infusion
The VA’s Close to Me program has trialled subcutaneous infusions in the home in rural settings to great success, enabling better access to care.
Expanding Therapies
Mayo Clinic’s Cancer Care Beyond Walls program is exploring expansion of home infusion into chemotherapies such as paclitaxel.
Expanding Therapies
Mayo Clinic’s Cancer Care Beyond Walls program is exploring expansion of home infusion into chemotherapies such as paclitaxel.
Expanding Therapies
Mayo Clinic’s Cancer Care Beyond Walls program is exploring expansion of home infusion into chemotherapies such as paclitaxel.
How it fits in
Our technologies are already in use across clinical settings and pilot programs. Each solution is designed to integrate with existing care pathways and teams—making adoption simple, scalable, and system-ready from day one.
How it fits in
Our technologies are already in use across clinical settings and pilot programs. Each solution is designed to integrate with existing care pathways and teams—making adoption simple, scalable, and system-ready from day one.
How it fits in
Our technologies are already in use across clinical settings and pilot programs. Each solution is designed to integrate with existing care pathways and teams—making adoption simple, scalable, and system-ready from day one.
“
When looking in the mirror, you find your old face coming back together with your hair.
”
Lily Clinical Trial Participant
“
When looking in the mirror, you find your old face coming back together with your hair.
”
Lily Clinical Trial Participant
“
When looking in the mirror, you find your old face coming back together with your hair.
”
Lily Clinical Trial Participant
A partner for employee wellbeing and retention
We work with employers and benefits providers to integrate cancer support into your existing plans—through pilots, modelling, and partnerships.
Together, we can reduce absenteeism, improve care satisfaction, and show employees that you’ve got their back when it matters most.
A partner for employee wellbeing and retention
We work with employers and benefits providers to integrate cancer support into your existing plans—through pilots, modelling, and partnerships.
Together, we can reduce absenteeism, improve care satisfaction, and show employees that you’ve got their back when it matters most.
A partner for employee wellbeing and retention
We work with employers and benefits providers to integrate cancer support into your existing plans—through pilots, modelling, and partnerships.
Together, we can reduce absenteeism, improve care satisfaction, and show employees that you’ve got their back when it matters most.
Let’s bring better support to the workplace
We partner with employers who want to offer smarter, more human cancer care.
If you’re exploring new benefits solutions or want to see how Luminate could fit into your program, we’d love to connect.
Let’s bring better support to the workplace
We partner with employers who want to offer smarter, more human cancer care.
If you’re exploring new benefits solutions or want to see how Luminate could fit into your program, we’d love to connect.
Let’s bring better support to the workplace
We partner with employers who want to offer smarter, more human cancer care.
If you’re exploring new benefits solutions or want to see how Luminate could fit into your program, we’d love to connect.
We provide technology-enabled solutions that help oncology healthcare professionals and health plans make cancer care better for patients.
Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.
We provide technology-enabled solutions that help oncology healthcare professionals and health plans make cancer care better for patients.
Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.
We provide technology-enabled solutions that help oncology healthcare professionals and health plans make cancer care better for patients.
Information on this website pertains to pre-clinical or clinical-stage medical devices in development that have not been approved by the Food and Drug Administration.